Shrikant Anant
Overview
Explore the profile of Shrikant Anant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
149
Citations
4150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Subramaniam D, May R, Sureban S, Lee K, George R, Kuppusamy P, et al.
Cancer Res
. 2022 Aug;
82(16):2951.
PMID: 35971679
No abstract available.
12.
Kasi A, Hentzen S, Gupta N, Poddutoori P, Madan R, Anant S, et al.
J Med Cases
. 2022 Feb;
13(1):26-30.
PMID: 35211232
Selective immunoglobin A deficiency (IgAD) is the most common immunodeficiency disorder in the western world. Cancer is the most common cause of death in these individuals. Various cases have been...
13.
Manley S, Olou A, Jack J, Ruckert M, Walsh R, Eades A, et al.
Cell Death Dis
. 2022 Feb;
13(2):165.
PMID: 35190546
No abstract available.
14.
Manley S, Olou A, Jack J, Ruckert M, Walsh R, Eades A, et al.
Cell Death Dis
. 2022 Feb;
13(2):114.
PMID: 35121743
Obesity creates a localized inflammatory reaction in the adipose, altering secretion of adipocyte-derived factors that contribute to pathologies including cancer. We have previously shown that adiponectin inhibits pancreatic cancer by...
15.
Ahmed I, Yusuf K, Roy B, Stubbs J, Anant S, Attard T, et al.
Int J Mol Sci
. 2022 Jan;
23(1).
PMID: 35008767
Decreases in short-chain-fatty-acids (SCFAs) are linked to inflammatory bowel disease (IBD). Yet, the mechanisms through which SCFAs promote wound healing, orchestrated by intestinal stem cells, are poorly understood. We discovered...
16.
Escher T, Dandawate P, Sayed A, Hagan C, Anant S, Lewis-Wambi J
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680281
Aromatase inhibitors (AIs) reduce estrogen levels up to 98% as the standard practice to treat postmenopausal women with estrogen receptor-positive (ER+) breast cancer. However, approximately 30% of ER+ breast cancers...
17.
He X, Smith S, Chen S, Li H, Wu D, Meneses-Giles P, et al.
Cell Rep
. 2021 Sep;
36(10):109674.
PMID: 34496236
Tumor-initiating stem cells (TSCs) are critical for drug resistance and immune escape. However, the mutual regulations between TSC and tumor microenvironment (TME) remain unclear. Using DNA-label retaining, single-cell RNA sequencing...
18.
Roy B, Ahmed I, Stubbs J, Zhang J, Attard T, Septer S, et al.
Cell Death Discov
. 2021 Aug;
7(1):200.
PMID: 34341333
No abstract available.
19.
Roy B, Ahmed I, Stubbs J, Zhang J, Attard T, Septer S, et al.
Cell Death Discov
. 2021 Jul;
7(1):169.
PMID: 34226497
Alternative promoter usage generates long and short isoforms (DCLK1-L and DCLK1-S) of doublecortin-like kinase-1 (DCLK1). Tight control of Notch signaling is important to prevent and restitute inflammation in the intestine....
20.
Subramaniam D, Ponnurangam S, Ramalingam S, Kwatra D, Dandawate P, Weir S, et al.
Cells
. 2021 Jul;
10(7).
PMID: 34206989
Honokiol (HNK) is a biphenolic compound that has been used in traditional medicine for treating various ailments, including cancers. In this study, we determined the effect of HNK on colon...